# Mechanical Ventilation in Veterinary Patients: Indications and Initial Settings ## Key Takeaways - Mechanical ventilation is indicated for refractory hypoxemia (PaO2 < 60 mmHg despite FiO2 > 0.6) or hypercapnic respiratory failure (PaCO2 > 60 mmHg with pH < 7.20), signifying inadequate spontaneous gas exchange. - Lung-protective ventilation strategies, derived from human ARDS literature, advocate for tidal volumes of 6-10 ml/kg ideal body weight and plateau pressures below 25-30 cm H2O to minimize volutrauma and barotrauma. - Initial ventilator settings include volume-controlled or pressure-controlled modes (SIMV often preferred for patient synchrony), an initial FiO2 of 1.0 to correct hypoxemia, and Positive End-Expiratory Pressure (PEEP) of 3-5 cm H2O (higher for hypoxemic patients) to recruit alveoli. - Close monitoring via serial arterial blood gas analysis (every 1-4 hours), ventilator parameter assessment (peak and plateau pressures), and hemodynamic evaluation is crucial for early detection of deterioration or ventilator dyssynchrony. - Species-specific considerations, such as increased equipment dead space in cats and potential airway collapse in brachycephalic dogs, necessitate tailored ventilator strategies and careful sedation management. - Permissive hypercapnia, accepting PaCO2 up to 60-70 mmHg with pH > 7.20, is a recognized strategy to achieve lung protection when tidal volume reduction is necessary, particularly in patients with parenchymal lung disease. --- Mechanical ventilation is a life-sustaining intervention in veterinary critical care, applied when spontaneous breathing fails to maintain adequate gas exchange or when the work of breathing threatens clinical stability. This article provides a decision framework for the practicing veterinarian: when to intubate and ventilate, how to select initial ventilator settings, and how to monitor the patient during the first hours of support. The focus is procedural, covering initiation and early management instead of long-term weaning protocols. The reader is assumed to be a qualified veterinarian with working knowledge of blood gas interpretation, airway management, and basic ventilator modes. Species differences between dogs and cats are highlighted where they affect ventilator strategy. The scientific basis for lung-protective ventilation is drawn from human ARDS literature, which remains the most robust evidence base available and informs current veterinary practice. ## At a Glance | Parameter | Initial Recommendation | Clinical Rationale | |---|---|---| | Indication threshold | PaO2 below 60 mm Hg or SpO2 below 90% despite FiO2 above 0.6 | Refractory hypoxemia defines ventilatory failure | | Indication threshold | PaCO2 above 60 mm Hg with pH below 7.20 | Hypercapnia with acidemia indicates inadequate alveolar ventilation | | Tidal volume | 6 to 10 ml/kg ideal body weight | Lung-protective strategy reduces volutrauma risk | | Plateau pressure limit | Below 25 to 30 cm H2O | Pressure limitation is central to lung protection | | FiO2 initial | 1.0, then titrate down | Avoid oxygen toxicity once ventilation is stable | | PEEP initial | 3 to 5 cm H2O, higher for hypoxemic patients | Recruits alveoli and maintains functional residual capacity | | Mode selection | Volume-controlled or pressure-controlled, synchronized intermittent mandatory ventilation | SIMV allows spontaneous effort and reduces sedation requirements | | Monitoring frequency | Blood gas and ventilator parameters every 1 to 4 hours | Early detection of deterioration or ventilator dyssynchrony | ## Physiologic Basis for Ventilatory Support ### Gas Exchange Failure and the Decision to Ventilate Respiratory failure is classified by mechanism. Hypoxemic failure, or type I, arises from ventilation-perfusion mismatch, intrapulmonary shunting, or diffusion impairment. Hypercapnic failure, or type II, results from alveolar hypoventilation relative to carbon dioxide production. Many veterinary patients present with mixed patterns, particularly those with pulmonary parenchymal disease, upper airway obstruction, or neuromuscular weakness. The decision to initiate mechanical ventilation rests on blood gas thresholds interpreted in clinical context. A PaO2 persistently below 60 mm Hg despite supplemental oxygen, or a PaCO2 rising above 60 mm Hg with accompanying acidemia, indicates that conservative therapy has failed. These thresholds are pragmatic guides instead of absolute rules. A patient with rapidly progressive disease may warrant earlier intervention, while a stable chronic hypercapnic patient may tolerate higher PaCO2 without ventilation. ### Lung Injury from Ventilation Itself Mechanical ventilation can injure healthy and diseased lungs alike. High tidal volumes and elevated airway pressures produce volutrauma and barotrauma, while cyclic opening and closing of atelectatic alveoli generates shear stress. The inflammatory response to this mechanical injury is well documented. Animal studies have shown that ventilation at high volume and pressure is deleterious to the lungs, and this observation drove the development of lung-protective strategies in human critical care. The inflammatory cascade extends beyond the lung. In experimental models, mechanical ventilation enhances release of inflammasome-regulated cytokines including IL-18, and neutralization of these mediators reduces lung injury in ventilated mice. This systemic inflammatory amplification is relevant to the veterinary patient with sepsis or trauma, where ventilator-induced lung injury can worsen multiorgan dysfunction. The practical implication is clear: the ventilator should be set to support gas exchange with the least injurious pattern achievable. ### Evidence for Lung-Protective Ventilation The human ARDS literature provides the foundational evidence for current ventilator strategy. A multicenter randomized trial compared a strategy limiting plateau pressure to 25 cm H2O with tidal volumes below 10 ml/kg against a conventional approach using tidal volumes of 10 ml/kg or higher targeting normal PaCO2. The low-volume strategy produced tidal volumes of approximately 7 ml/kg and plateau pressures near 26 cm H2O, with permissive hypercapnia accepted. Mortality at day 60 did not differ significantly between groups, but the trial established that low-volume, pressure-limited ventilation is feasible and safe in severe ARDS. Earlier observational work supported this approach. A series of patients with severe ARDS managed with pressure-limited ventilation and permissive hypercapnia showed hospital mortality substantially lower than predicted by severity scoring. The authors attributed this outcome to avoidance of high peak inspiratory pressures. These studies, though human, inform veterinary practice because the biophysical principles of lung injury are species-independent. Dogs and cats with diffuse alveolar disease are at similar risk of ventilator-induced injury as human patients with ARDS. ## Ventilator Modes and Initial Selection ### Volume-Controlled Versus Pressure-Controlled Ventilation Volume-controlled ventilation delivers a preset tidal volume with variable airway pressure. Pressure-controlled ventilation delivers a preset inspiratory pressure with variable tidal volume. Both are acceptable for initial support. Volume-controlled modes guarantee minute ventilation, which is advantageous when compliance is changing rapidly. Pressure-controlled modes limit peak airway pressure directly, which may be preferable in patients with stiff lungs or air leak risk. Synchronized intermittent mandatory ventilation is the most commonly selected initial mode in veterinary practice. It delivers a preset number of mandatory breaths synchronized to patient effort, while permitting spontaneous breaths between mandatory cycles. This preserves respiratory muscle activity and reduces the depth of sedation required. For apneic or heavily sedated patients, assist-control modes that trigger on every patient effort may be more appropriate. ### Tidal Volume and Pressure Targets Initial tidal volume should be calculated from ideal body weight, not actual weight, particularly in obese or edematous patients. A starting point of 8 ml/kg is reasonable for most dogs and cats, with adjustment downward toward 6 ml/kg in patients with diffuse parenchymal disease or known low compliance. Plateau pressure, measured during an end-inspiratory pause, should be kept below 25 to 30 cm H2O. If plateau pressure exceeds this limit, tidal volume should be reduced even at the cost of hypercapnia, provided pH remains above 7.20. ### Positive End-Expiratory Pressure and FiO2 Initial FiO2 is set at 1.0 to correct hypoxemia rapidly, then titrated downward to the lowest value maintaining SpO2 above 92% or PaO2 above 65 mm Hg. Prolonged exposure to high FiO2 causes absorption atelectasis and oxygen toxicity, so downward titration should begin as soon as oxygenation stabilizes. PEEP is initiated at 3 to 5 cm H2O for most patients. Higher PEEP, in the range of 8 to 12 cm H2O, is indicated for patients with refractory hypoxemia from alveolar collapse or pulmonary edema. PEEP recruits collapsed alveoli, improves ventilation-perfusion matching, and maintains functional residual capacity. Excessive PEEP reduces cardiac output by increasing intrathoracic pressure and impeding venous return, so hemodynamic monitoring is essential when PEEP is raised. ## Sedation and Neuromuscular Blockade ### Goals of Sedation During Mechanical Ventilation Most veterinary patients require sedation to tolerate an endotracheal tube and synchronize with the ventilator. The goal is a patient who is calm, comfortable, and breathing in phase with the ventilator without excessive respiratory effort. Continuous rate infusion of a benzodiazepine combined with an opioid is a common starting approach. Phenothiazines and alpha-2 agonists may be added for refractory agitation, though their cardiovascular effects require consideration in unstable patients. ### Neuromuscular Blocking Agents Neuromuscular blocking agents are reserved for patients with severe ventilator dyssynchrony, refractory hypoxemia, or critically elevated intracranial pressure. These agents eliminate respiratory effort entirely, allowing precise control of ventilation but removing the patient's own respiratory drive as a safety mechanism. They also abolish the cough reflex and require meticulous eye care and recumbency management. If neuromuscular blockade is used, adequate sedation must be guaranteed, and the patient must be monitored continuously by trained personnel. ## Monitoring During Initial Ventilation ### Blood Gas Analysis and Ventilator Parameters Arterial blood gas analysis is performed within 15 to 30 minutes of initiating ventilation, then at intervals of 1 to 4 hours depending on stability. PaO2, PaCO2, and pH are interpreted against the ventilator settings in use. A rising PaCO2 with stable settings indicates worsening dead space or falling minute ventilation. A falling PaO2 may indicate progressive atelectasis, worsening pulmonary pathology, or endotracheal tube displacement. Peak inspiratory pressure and plateau pressure are recorded with each blood gas. A rising peak pressure with stable plateau pressure suggests increased airway resistance, as from bronchospasm or secretions. A rise in both pressures indicates decreased compliance, as from pulmonary edema, pneumothorax, or abdominal distension. End-tidal carbon dioxide monitoring provides continuous trending but may underestimate PaCO2 in patients with increased dead space. ### Hemodynamic and Physical Monitoring Mechanical ventilation affects cardiovascular function through increased intrathoracic pressure, which reduces venous return and can decrease cardiac output. Blood pressure, heart rate, and perfusion parameters are monitored closely, particularly after any increase in PEEP or change in ventilator mode. Mucous membrane color, capillary refill time, and urine output provide indirect assessment of tissue perfusion. The patient is assessed regularly for evidence of barotrauma. Subcutaneous emphysema, sudden deterioration in oxygenation, or unexplained hypotension may indicate pneumothorax. Ventilated patients should be positioned in sternal recumbency when possible to optimize ventilation-perfusion matching, with regular repositioning to prevent dependent atelectasis and pressure sores. ## Initial Ventilator Settings by Disease Category The initial ventilator prescription should be guided by the underlying disease process, the patient's lung mechanics, and the primary indication for support. A patient with normal lungs ventilated for intracranial disease requires different settings than a patient with diffuse alveolar damage and reduced pulmonary compliance. The table below provides a framework for initial settings based on disease category. | Disease Category | Tidal Volume (mL/kg) | Mode | PEEP (cm H2O) | FiO2 Target | Respiratory Rate (breaths/min) | |---|---|---|---|---|---| | Normal lungs (neurologic, neuromuscular, anesthesia) | 10 to 12 | Volume-controlled A/C or SIMV | 3 to 5 | Lowest to maintain SpO2 > 94% | 10 to 14 (dog), 14 to 20 (cat) | | Restrictive parenchymal disease (ARDS, pneumonia, pulmonary contusions) | 6 to 8 | Volume-controlled A/C with pressure limit | 5 to 10, titrated to oxygenation | Lowest to maintain SpO2 88 to 92% | 14 to 20 (dog), 20 to 30 (cat) | | Obstructive airway disease (bronchospasm, chronic bronchitis) | 8 to 10 | Volume-controlled A/C, prolonged expiratory time | 0 to 5 | Lowest to maintain SpO2 > 92% | 8 to 12 (dog), 12 to 16 (cat) | | Severe hypoxemia refractory to moderate PEEP | 6 to 8 | Pressure-controlled A/C | 10 to 15, titrated | 100% initially, wean rapidly | 12 to 20 (dog), 20 to 30 (cat) | Tidal volume should be calculated from ideal body weight, not measured body weight, particularly in obese or heavily muscled patients. The ARDS literature in human medicine demonstrated that a strategy limiting plateau pressure to 25 cm H2O with tidal volumes below 10 mL/kg produced comparable mortality to conventional ventilation, and permissive hypercapnia was well tolerated in that cohort. The same trial showed that the low-volume group required significantly higher PaCO2 and lower pH, yet outcomes were not worse, supporting the safety of accepting respiratory acidosis when lung protection demands it. In veterinary patients, the same physiologic principles apply, though prospective outcome data are lacking. For patients with normal pulmonary compliance, higher tidal volumes are acceptable and may be necessary to maintain adequate minute ventilation. For patients with reduced compliance, tidal volume should be reduced and respiratory rate increased to compensate. Plateau pressure should be measured and kept below 20 cm H2O in patients with normal lungs and below 15 cm H2O where feasible in patients with parenchymal disease. ## Positive End-Expiratory Pressure Titration Positive end-expiratory pressure serves three functions: recruitment of collapsed alveoli, maintenance of functional residual capacity, and improvement of ventilation-perfusion matching. The optimal PEEP is the lowest value that achieves an acceptable SpO2 or PaO2 at a non-toxic FiO2. A common target is SpO2 greater than 92% or PaO2 greater than 80 mm Hg at an FiO2 of 0.4 or less. PEEP should be increased in increments of 2 to 3 cm H2O with assessment of oxygenation, blood pressure, and lung compliance after each change. If oxygenation does not improve after two consecutive increments, further increases are unlikely to help and may cause harm. PEEP can be decreased when FiO2 has been weaned to 0.3 or less and the patient remains stable. The adverse effects of PEEP include reduced venous return, decreased cardiac output, increased intracranial pressure, and overdistension of already compliant lung regions. Hypotension after a PEEP increase should prompt immediate reduction to the previous setting. The [AAHA and AAFP fluid therapy guidelines](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/) emphasize that volume status should be assessed before and during PEEP titration, as hypovolemic patients are particularly susceptible to the hemodynamic consequences of positive pressure. ## FiO2 Management Initial FiO2 should be set to achieve rapid correction of hypoxemia, then weaned aggressively. A starting FiO2 of 1.0 is appropriate for patients with severe hypoxemia or during the immediate post-intubation period. FiO2 should be reduced by 0.1 to 0.2 every 15 to 30 minutes until the lowest value that maintains target oxygenation is reached. Prolonged exposure to high FiO2 causes absorption atelectasis and can contribute to oxidative lung injury. The goal is an FiO2 of 0.4 or less within the first 6 to 12 hours of ventilation. If FiO2 cannot be weaned below 0.6 without hypoxemia, PEEP should be increased instead of continuing high FiO2. ## Blood Gas Monitoring Sheet Arterial blood gas analysis is the primary monitoring tool during initial ventilation. Sampling should occur 15 to 30 minutes after any ventilator setting change, then at 4 to 6 hour intervals once stable. The following monitoring sheet provides a structured approach to interpretation. | Parameter | Target Range | Action if Low | Action if High | |---|---|---|---| | PaO2 | 80 to 100 mm Hg | Increase FiO2 or PEEP | Wean FiO2, consider decreasing PEEP | | SpO2 | 92 to 98% | Check blood gas, increase FiO2 or PEEP | Wean FiO2 | | PaCO2 | 35 to 45 mm Hg (normal lungs) | Decrease respiratory rate or tidal volume | Increase respiratory rate or tidal volume | | PaCO2 | 45 to 60 mm Hg (permissive hypercapnia) | Accept if pH > 7.20 | Increase rate if pH < 7.20 | | pH | 7.35 to 7.45 | Evaluate metabolic component, increase ventilation | Decrease ventilation, evaluate metabolic alkalosis | | Plateau pressure | < 20 cm H2O | Not applicable | Decrease tidal volume, assess compliance | | End-tidal CO2 | 35 to 45 mm Hg | Check arterial PaCO2 correlation | Check arterial PaCO2 correlation | The correlation between end-tidal CO2 and arterial PaCO2 should be established early in ventilation. In patients with increased alveolar dead space, such as those with pulmonary thromboembolism or severe hypovolemia, the gradient widens and end-tidal CO2 underestimates arterial PaCO2. The gradient should be reassessed after any significant change in hemodynamic status. Permissive hypercapnia is acceptable in patients with parenchymal lung disease when tidal volume reduction is required for lung protection. The human trial by Hickling and colleagues demonstrated that limiting peak inspiratory pressure and allowing PaCO2 to rise to a mean of 62 mm Hg was associated with lower than predicted mortality in severe ARDS. In veterinary patients, PaCO2 up to 60 to 70 mm Hg is generally tolerated if pH remains above 7.20 and there is no concurrent intracranial pathology, cardiac arrhythmia, or pulmonary hypertension. ## Species-Specific Considerations Cats present unique challenges during mechanical ventilation. Their small size amplifies the effect of equipment dead space, and the endotracheal tube and ventilator circuit can add significant dead space relative to tidal volume. A 3 kg cat with a tidal volume of 24 mL may have circuit dead space of 10 to 15 mL, substantially reducing effective alveolar ventilation. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) notes that cats are also prone to bradycardia and hypotension with positive pressure ventilation due to enhanced vagal tone and sensitivity to decreased venous return. Dogs with brachycephalic conformation may have pre-existing upper airway obstruction and increased work of breathing. These patients often require higher inspiratory pressures to overcome airway resistance and may need a longer inspiratory time. The transition from spontaneous to controlled ventilation in these patients can precipitate dynamic airway collapse, and sedation depth must be sufficient to prevent fighting the ventilator. ## Documentation and Communication Ventilator settings, blood gas results, and patient response should be recorded at least every 4 hours during the initial stabilization period. The record should include mode, tidal volume, respiratory rate, FiO2, PEEP, peak inspiratory pressure, plateau pressure, SpO2, end-tidal CO2, heart rate, blood pressure, and sedation score. Any change in settings and the indication for that change should be documented contemporaneously. The veterinary team should establish clear communication protocols for ventilator management. The [RECOVER Initiative guidelines](https://recoverinitiative.org/) emphasize structured team communication during resuscitation and post-arrest care, and the same principles apply to ventilator management. A designated individual should be responsible for ventilator monitoring at all times, and escalation criteria for veterinary assistance should be defined in advance. ## Recognized Complications and Early Detection Ventilator-induced lung injury remains the most consequential complication of mechanical ventilation. High tidal volumes and elevated plateau pressures produce volutrauma and barotrauma, while repetitive opening and closing of atelectatic alveoli generates shear injury. The Multicenter Trial Group on Tidal Volume Reduction in ARDS demonstrated that a strategy limiting plateau pressure to 25 cm H2O with tidal volumes below 10 ml/kg produced lower airway pressures but did not reduce mortality compared with conventional ventilation, underscoring that the relationship between pressure limitation and outcome is not straightforward ([tidal volume reduction for prevention of ventilator-induced lung injury](https://pubmed.ncbi.nlm.nih.gov/9847275/)). Experimental work has since identified inflammasome-regulated cytokines, particularly IL-18, as mediators of ventilation-associated lung injury, suggesting that inflammatory amplification instead of purely mechanical disruption drives much of the damage ([inflammasome-regulated cytokines in acute lung injury](https://pubmed.ncbi.nlm.nih.gov/22461369/)). Early detection relies on serial assessment instead of single measurements. Rising peak inspiratory pressure with stable plateau pressure indicates increased airway resistance, commonly from secretions, bronchospasm, or endotracheal tube obstruction. Rising plateau pressure with stable peak pressure suggests decreased compliance from pulmonary edema, atelectasis, or progressive parenchymal disease. Auto-positive end-expiratory pressure should be suspected when expiratory flow does not return to zero before the next breath, when triggering becomes erratic, or when unexplained hypotension develops. Pulse oximetry trends, capnography waveforms, and arterial blood gas values obtained 30 to 60 minutes after each setting change provide the earliest objective evidence of deterioration. ## Common Errors and Corrective Action Less experienced clinicians frequently set tidal volumes by actual body weight instead of ideal body weight. Obese patients and those with pleural effusion or ascites receive inappropriately large volumes relative to their ventilated lung mass. Calculate tidal volume from an estimated ideal weight based on body condition score and breed, then verify with plateau pressure measurement. A second recurring error is aggressive correction of PaCO2. Permissive hypercapnia is an accepted strategy in lung-protective ventilation, and the early experience reported by Hickling and colleagues showed that accepting PaCO2 values up to 129 mmHg was associated with lower than predicted mortality in severe ARDS ([low mortality with permissive hypercapnia in severe ARDS](https://pubmed.ncbi.nlm.nih.gov/2246418/)). Clinicians should tolerate respiratory acidosis to a pH of approximately 7.20 in most patients, reserving aggressive ventilation for those with intracranial pathology or refractory hemodynamic instability. Disconnection of the patient from the ventilator during transport or procedures is frequently overlooked as a source of rapid deterioration. Every ventilator circuit should have a disconnect alarm enabled, and manual ventilation should be available at the bedside. Finally, clinicians often fail to re-evaluate settings after the first 24 hours. The patient who improves requires progressive reduction in FiO2 and positive end-expiratory pressure, while the patient who deteriorates may need a different mode or higher positive end-expiratory pressure, not simply more sedation. ## Troubleshooting Table | Observation | Likely Cause | Discriminating Check | |---|---|---| | Rising peak pressure, stable plateau | Airway resistance: secretions, tube kink, bronchospasm | Pass suction catheter, auscultate, check tube position | | Rising plateau pressure, stable peak | Reduced compliance: pulmonary edema, atelectasis, pneumothorax | Chest radiography, lung ultrasound, passive expiratory volume | | Erratic triggering or dyssynchrony | Auto-PEEP, inadequate sedation, circuit leak | Expiratory hold maneuver, inspect circuit connections | | Sudden hypotension | Auto-PEEP, hypovolemia, tension pneumothorax | Expiratory hold, blood pressure trend, thoracic ultrasound | | Rising PaCO2 with stable settings | Increased dead space, reduced cardiac output, circuit leak | Capnography waveform, minute volume check, blood gas | ## Evidence Limitations and Areas of Disagreement The evidence base for mechanical ventilation in veterinary patients is largely extrapolated from human critical care and experimental animal models. The landmark human trials cited here enrolled patients with ARDS and excluded those with organ failure beyond the lung, a population that differs substantially from many veterinary patients with concurrent trauma, sepsis, or cardiac disease ([tidal volume reduction for prevention of ventilator-induced lung injury](https://pubmed.ncbi.nlm.nih.gov/9847275/)). The RECOVER Initiative provides evidence-evaluated consensus guidelines for CPR and post-arrest care, but does not address ventilator management in non-arrest settings ([RECOVER veterinary CPR guidelines](https://recoverinitiative.org/)). Expert opinion still differs on optimal positive end-expiratory pressure titration, on the relative merits of pressure-controlled versus volume-controlled modes, and on whether open lung strategies confer benefit beyond simple pressure limitation. Some authorities advocate routine neuromuscular blockade in the first 48 hours, others reserve it for refractory dyssynchrony. Neither position is supported by veterinary-specific outcome data. ## Referral and Escalation Patients that fail to achieve oxygenation targets despite FiO2 above 0.6 and positive end-expiratory pressure above 10 cm H2O, patients with refractory hypotension, and patients requiring escalating vasopressor support should be discussed with a veterinary critical care specialist. Transfer to a 24-hour facility with dedicated critical care staffing is appropriate when the primary hospital cannot provide continuous monitoring, when ventilator alarms cannot be answered immediately, or when nursing ratios exceed one technician per ventilated patient. Laboratory involvement is indicated for serial blood gas analysis, electrolyte monitoring, and assessment of organ function. Regulatory reporting may apply when ventilation is provided to animals covered by specific welfare legislation or when complications arise during procedures performed under regulatory oversight. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) address welfare during veterinary interventions in production animals, and the [AVMA practice resources](https://www.avma.org/resources-tools) provide guidance on professional obligations in critical care settings. Clinicians should document ventilator settings, blood gas results, and complications contemporaneously, and should communicate the prognosis and treatment plan to the owner at regular intervals. ## Frequently Asked Questions ### What Are the Minimum Monitoring Capabilities Required Before Initiating Mechanical Ventilation? Continuous electrocardiography, pulse oximetry, and capnography are essential. A blood gas analyzer must be available on site or within minutes of transport, because ventilator adjustments rely on serial arterial or venous blood gas measurements. Direct or indirect blood pressure monitoring is required, as positive pressure ventilation reduces venous return and cardiac output. A mechanical ventilator with adjustable tidal volume, respiratory rate, FiO2, and positive end-expiratory pressure is mandatory. Volume-controlled modes require a disconnect alarm. The [RECOVER Initiative veterinary CPR guidelines](https://recoverinitiative.org/) emphasize that post-arrest patients are hemodynamically unstable, so invasive blood pressure monitoring is strongly preferred in that population. ### How Should I Proceed When Only a Manual Resuscitator Is Available? Manual ventilation with a self-inflating bag and an inline manometer is acceptable for short-term support while arranging transport or equipment. Attach a manometer to avoid peak pressures above 20 to 25 cm H2O in dogs and 15 to 20 cm H2O in cats. Ventilate at 10 to 14 breaths per minute in dogs and 12 to 20 breaths per minute in cats, delivering just enough volume to produce a visible chest rise. Deliver 100% oxygen during manual ventilation. This approach cannot provide positive end-expiratory pressure reliably, so recruit collapsed alveoli with sustained manual inflation to 20 cm H2O for 10 to 15 seconds, then resume regular breaths. Monitor pulse oximetry and capnography continuously. Manual ventilation is tiring for staff, so rotate operators every 15 to 20 minutes. ### What Is the Role of Neuromuscular Blockade in the First Hour of Ventilation? Neuromuscular blocking agents are reserved for patients whose respiratory effort triggers the ventilator, causes breath stacking, or produces plateau pressures above the target despite deep sedation. They are also useful in patients with profound hypoxemia where any asynchronous breath worsens gas exchange. When used, a continuous rate infusion is preferred over intermittent boluses, and the patient must be deeply sedated first. Train-of-four monitoring is ideal but rarely available in veterinary practice, so assess for return of spontaneous effort every 30 to 60 minutes by pausing the infusion. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) notes that species differences in drug metabolism affect duration of action, so current formulary references must be consulted before selecting an agent. ### How Do I Explain the Decision to Ventilate to an Owner Who Is Hesitant? Frame the conversation around the patient's immediate inability to oxygenate or eliminate carbon dioxide despite maximal medical therapy. Explain that mechanical ventilation is supportive, not curative, and that the underlying disease determines the outcome. Provide a realistic range for survival based on the diagnosis, but avoid quoting specific statistics unless they come from the patient's own hospital data. Describe the monitoring intensity, the need for 24-hour observation, and the expected duration of support in days instead of hours. Discuss the financial estimate in writing, including a daily breakdown and a contingency for complications. The [AVMA practice resources](https://www.avma.org/resources-tools) offer guidance on informed consent and financial communication that applies to this conversation. ### What Initial Settings Are Appropriate for a Neonatal or Pediatric Patient? Neonates and pediatric patients have higher metabolic rates, lower functional residual capacity, and more compliant chest walls than adults. Use pressure-controlled ventilation with a peak inspiratory pressure of 10 to 15 cm H2O and a respiratory rate of 20 to 40 breaths per minute. Set positive end-expiratory pressure at 3 to 5 cm H2O and FiO2 at the lowest value that maintains SpO2 above 94%. Tidal volume targets of 6 to 8 ml/kg still apply, but the delivered volume must be measured at the airway because circuit compliance distorts estimates. These patients are prone to hypothermia and hypotension during ventilation, so warming and fluid support are priorities. The [AAHA/AAFP fluid therapy guidelines](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/) address the increased fluid sensitivity of pediatric patients. ### How Should Ventilator Settings and Patient Status Be Documented in the Medical Record? Document ventilator mode, FiO2, tidal volume, respiratory rate, peak inspiratory pressure, plateau pressure, positive end-expiratory pressure, and minute ventilation at least every hour for the first 24 hours. Record the most recent blood gas values, including pH, PaCO2, PaO2, and calculated indices such as PaO2/FiO2. Note the sedation score, spontaneous respiratory rate, and any asynchronous breathing events. Document every change in settings, the reason for the change, and the patient's response within 15 minutes. Include a flowsheet entry for hemodynamic parameters, urine output, and lung auscultation findings. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) emphasize that complete medical records support both clinical continuity and welfare assessment, and this principle applies directly to ventilator management. ## Related Clinical & Scientific Guides * [Toxicology in Emergency Practice: Common Poisons and Diagnostic Approach](/knowledge/veterinary-medicine/emergency-critical-care/toxicology-emergency-practice-common-poisons-diagnostic-approach) * [Veterinary Cardiopulmonary Resuscitation: Post-Cardiac Arrest Care](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-cardiopulmonary-resuscitation-post-cardiac-arrest-care) * [Fluid Therapy Guidelines for Dogs and Cats: A Practical Update](/knowledge/veterinary-medicine/emergency-critical-care/fluid-therapy-guidelines-dogs-cats-practical-update) ## References and Further Reading - [Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS.](https://pubmed.ncbi.nlm.nih.gov/9847275/). 1998. - [Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.](https://pubmed.ncbi.nlm.nih.gov/10470743/). 1999. - [Inflammasome-regulated cytokines are critical mediators of acute lung injury.](https://pubmed.ncbi.nlm.nih.gov/22461369/). 2012. - [Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome.](https://pubmed.ncbi.nlm.nih.gov/2246418/). 1990. - [Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance.](https://pubmed.ncbi.nlm.nih.gov/3004270/). 1986. - [Laboratory models of sepsis and septic shock.](https://pubmed.ncbi.nlm.nih.gov/2199735/). 1990. - [RECOVER Initiative Veterinary CPR Guidelines](https://recoverinitiative.org/). Veterinary Emergency and Critical Care Society. - [AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/). AAHA. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. ## Related Articles - [Failure Modes in Mechanical Ventilation of Veterinary Patients](/knowledge/veterinary-medicine/emergency-critical-care/failure-modes-mechanical-ventilation-veterinary-patients) - [Veterinary Mechanical Ventilation Weaning and Troubleshooting](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-mechanical-ventilation-weaning-troubleshooting) - [Complications of Oxygen Therapy in Veterinary Patients](/knowledge/veterinary-medicine/emergency-critical-care/complications-oxygen-therapy-veterinary-patients) - [Veterinary Plasma Transfusion: Indications and Administration](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-plasma-transfusion-indications-administration) - [Coagulation Emergencies in Small Animals: Diagnosis and Management](/knowledge/veterinary-medicine/emergency-critical-care/coagulation-emergencies-small-animals-diagnosis-management) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.